Table 2.
Serum 25(OH)D and biochemical components of MetS in adolescent girls aged 14–17 years, Boukan, Iran, winter 2012 (n 216)
| Summary statistics | ||
|---|---|---|
| Mean or n | sd or % | |
| 25(OH)D (ng/ml) | 7·26 | 2·81 |
| 25(OH)D < 20 ng/ml† | 207 | 95·8 |
| 20 ng/ml < 25(OH)D < 30 ng/ml† | 9 | 4·2 |
| FBG (mg/dl) | 90·0 | 9·7 |
| FBG ≥ 110 (mg/dl)† | 30 | 13·9 |
| TAG (mg/dl) | 84·4 | 37·1 |
| TAG ≥ 100 (mg/dl)† | 57 | 26·4 |
| HDL-C (mg/dl) | 50·0 | 10·9 |
| HDL-C < 50 (mg/dl)† | 116 | 53·7 |
25(OH)D, serum 25-hydroxyvitamin D; MetS, metabolic syndrome; FBG, fasting blood glucose; HDL-C, HDL-cholesterol.
†Data are expressed as n and %.